Clinically significant drug-drug interactions between tramadol and CYP3A4 inhibitors: disproportionality analysis in VigiBase® and hypothesis on the underlying mechanism.
Clémence DelafoyCharles DolladillePaul BesnierMarion SassierJoanna BourgineVéronique Lelong-BoulouardJoachim AlexandreCyril GuillaumeSophie FedrizziBasile ChrétienPublished in: European journal of clinical pharmacology (2020)
Keyphrases